Jiedu Sangen Decoction inhibits Epithelial-mesenchymal transition of colon adenocarcinoma via POU4F2/Hedgehog pathway
Journal of Ethnopharmacology · 2026
DOI: 10.1016/j.jep.2025.120752 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2026. Verfasst von Pei-Pei Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Colonic Neoplasms, Adenocarcinoma, Drugs, Chinese Herbal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation.
Abstract (Originalsprache)
ETHNOPHARMACOLOGICAL RELEVANCE: Jiedu Sangen Decoction (JSD), a traditional Chinese medicine formulation used for colorectal cancer (CRC) in East China, is a multi-component and multi-target agent whose mechanisms remain unclear. AIM OF THE STUDY: This study evaluated the antitumor efficacy of JSD and investigated its mechanism of action via the POU4F2/Hedgehog signaling axis and epithelial-mesenchymal transition (EMT) cascade. MATERIALS AND METHODS: UPLC-Q/TOF-MS identified quality control markers in JSD. Anti-metastatic effects were assessed using colony formation, wound healing, and Transwell assays in colon adenocarcinoma (COAD) cells. EMT and Hedgehog (Hh) pathway markers were examined by Western blot and RT-qPCR. An allograft tumor model validated in vivo efficacy, and bioinformatics analysis correlated POU4F2 expression with COAD prognosis. RESULTS: JSD inhibited COAD cell proliferation, migration, and invasion. Mechanistically, it suppressed the POU4F2/Hedgehog axis, reversing EMT via E-cadherin upregulation and N-cadherin downregulation. These findings were consistent in vitro, where JSD also attenuated tumor growth. CONCLUSION: JSD suppresses COAD metastasis by inhibiting EMT through the POU4F2/Hh pathway, highlighting its potential as an integrative therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, China.
- The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, China; Academy of Chinese Medical Science, Zhejiang Chinese Medical Un…
Förderung
- China Postdoctoral Science Foundation
Zitieren
APA
Wang, P. P., Liu, Q. Y., Liu, H. X., Xia, Y. W., Shen, D. Y., Shen, M. H., Ruan, S. M., & Sun, L. T. (2026). Jiedu Sangen Decoction inhibits Epithelial-mesenchymal transition of colon adenocarcinoma via POU4F2/Hedgehog pathway. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2025.120752
Vancouver
Wang PP, Liu QY, Liu HX, Xia YW, Shen DY, Shen MH, et al. Jiedu Sangen Decoction inhibits Epithelial-mesenchymal transition of colon adenocarcinoma via POU4F2/Hedgehog pathway. Journal of Ethnopharmacology. 2026. doi:10.1016/j.jep.2025.120752
BibTeX
@article{Wang2026,
author = {Wang, Pei-Pei and Liu, Qing-Yang and Liu, Hong-Xi and Xia, Yu-Wei and Shen, De-Yi and Shen, Min-He and Ruan, Shan-Ming and Sun, Lei-Tao},
title = {Jiedu Sangen Decoction inhibits Epithelial-mesenchymal transition of colon adenocarcinoma via POU4F2/Hedgehog pathway},
journal = {Journal of Ethnopharmacology},
year = {2026},
doi = {10.1016/j.jep.2025.120752}
}
EUVIMED